Official Publications Novartis AG

Equities

NOVN

CH0012005267

Real-time Estimate Cboe Europe Other stock markets 03:03:19 2024-05-15 EDT			5-day change	1st Jan Change
93.56 ^CHF	+0.07%		+4.13%	+10.16%

05-13	Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales	DJ
05-10	Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation	MT

Official Publications

1st-half-year results	22-07-18	CO
1st-half-year results	22-07-18	CO
1st-half-year results	22-07-18	CO
Half-year report	22-07-18	CO
Slide show Q1	22-04-25	CO
1st quarter results	22-04-25	CO
1st quarter results	22-04-25	CO
1st quarter results	22-04-25	CO
1st quarter report	22-04-25	CO

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Novartis: 2024 has started on a strong note; guidance upgraded

NOVARTIS : 2024 has started on a strong note; guidance upgraded

April 23, 2024 at 01:24 pm

Vas Narasimhan, CEO of Novartis: 40% margin by 2027

April 23, 2024 at 07:18 am

Vas Narasimhan, CEO of Novartis: 40% margin by 2027

Novartis AG : Sandoz takes its first steps on the stock exchange

October 04, 2023 at 10:32 am

Novartis AG : Sandoz takes its first steps on the stock exchange

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW